Posted on 3/5/19
CompanionMx Among 25 Accepted to MIT Startup Exchange, STEX25
BOSTON--(BUSINESS WIRE)--CompanionMx, Inc., a digital health technology company focused on mobile behavioral health monitoring for patients and clinicians, today announced its acceptance to STEX25. STEX25 is . . .
Posted on 3/5/19
Biogen Takes Issue With Incomplete Coverage Of Spinraza In Canada
In a statement, Biogen (NASDAQ:BIIB) is "disappointed" with the limited access of spinal muscular atrophy (SMA) med SPINRAZA (nusinersen) in Canada.Apparently, the provinces themselves will decide . . .
Posted on 3/5/19
Good Will Hunting: CVS Health Decline Explained
SummaryCVS accountants went Good Will Hunting and found that the company overpaid for Omnicare.2019 estimates also came in below Wall Street estimates.The challenge now is to . . .
Posted on 3/5/19
Stock Market Today: Biogen Buys Gene Therapy Company Nightstar Therapeutics
It was an up-and-down session on Wall Street Monday, with stocks opening higher but falling in the morning. The Dow Jones Industrial Average (DJINDICES:^DJI) and the . . .
Posted on 3/4/19
Dicerna Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the Compensation Committee of the Company's Board of . . .
Posted on 3/4/19
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, . . .
Posted on 3/4/19
Biogen To Acquire Nightstar Therapeutics For $800M
Nightstar Therapeutics plc (NASDAQ: NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases and Biogen Inc.
Posted on 3/4/19
Thermo Fisher: A Growing Company With An Acquisition Strategy
SummaryThermo Fisher is a profitable company with moderate debt levels.The company’s earnings have shown strong growth over the last five years with more growth expected for . . .
Posted on 3/4/19
How Is CVS Health Changing Its Business?
Ever since CVS (NYSE:CVS) changed its name to CVS Health, the company has been trying to embrace that name. That started with the chain stopping the . . .
Posted on 3/4/19
What Happens Next for CVS and Aetna?
CVS (NYSE:CVS) has a deal in place to acquire Aetna. That will transform the company but it has yet to receive final regulatory approval. Whether that . . .
Posted on 3/4/19
The 3 Oldest Members of Biotech's Billion-Burned Club
Believe it or not, most professionals in the weird world of drug development would rather be lucky than smart. That's because 99.99% of potential new drugs . . .
Posted on 3/3/19
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to five new employees for an . . .
Posted on 3/3/19
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, March 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today . . .
Posted on 3/3/19
Mersana Therapeutics Prices Public Offering of Common Stock
CAMBRIDGE, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .
Posted on 3/3/19
Peak Physical Therapy & Sports Performance Appoints Kaylee LaCavalier, DPT as Staff Physical Therapist
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, is . . .
Posted on 3/1/19
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on February . . .
Posted on 3/1/19
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that it has granted stock options to . . .
Posted on 3/1/19
Mersana Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .
Posted on 2/28/19
Variantyx Launches Its RareDx Program
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx today announced the launch of its RareDx program which will help enrolled patients identify the molecular cause underlying their clinical symptoms by providing . . .
Posted on 2/28/19
Karyopharm Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
NEWTON, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today reported financial results for the fourth quarter and full . . .
Posted on 2/28/19
Concert Pharmaceuticals Reports Year Ended 2018 Financial Results and Provides Update on Clinical Programs
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) today reported financial results for the year ended December 31, 2018, as well as provided an update on its product . . .
Posted on 2/28/19
A Tale of 2 M&As: The Kraft Heinz Debacle, and Danaher's Pickup of GE Biopharma
The world of mergers and acquisitions is a peculiar place. On the one hand, you have activists demanding that large businesses sell off pieces of their . . .
Posted on 2/28/19
3 Stocks Warren Buffett Would Love
Even if Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) didn't have an absurd amount of cash on the books, there is always some speculation and guessing around what Warren . . .
Posted on 2/28/19
Kaleido Biosciences Prices IPO
LEXINGTON, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential . . .
Posted on 2/27/19
XSurgical Accepted for Membership in MTEC – Medical Technology Enterprise Consortium
XSurgical, a firm developing and bringing to market a remotely controlled surgical robot, has been accepted for membership in the Medical Technology Enterprise Consortium (MTEC), a . . .

